Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

Novo Nordisk · Phase 3 · Completed · Enrollment 512

NCT05649137

EudraCT 2022-002235-60

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide 7.2 mg89 participants51 participants56 participantsn/r4
Semaglutide 2.4 mg29 participants14 participants21 participantsn/r1
Placebo12 participants3 participants9 participantsn/r1

A count stays a count. This page does not turn a count into a percent.